Literature DB >> 32777175

Rezum water vapour therapy: promising early outcomes from the first UK series.

Maximilian J Johnston1,2, Mohamed Noureldin1,3, Yehia Abdelmotagly1, Louise Paramore1, Tina Gehring1, Timothy G Nedas1, Govindaraj Rajkumar1, Amr Emara1,3, Richard G Hindley1,4.   

Abstract

Entities:  

Year:  2020        PMID： 32777175     DOI： 10.1111/bju.15203

Source DB:  PubMed          Journal:  BJU Int        ISSN： 1464-4096            Impact factor:   5.588


× No keyword cloud information.
  3 in total

Review 1.  Rezum: a novel minimally invasive treatment for lower urinary tract symptoms secondary to benign prostatic hyperplasia. A review article.

Authors:  Ahmed Higazy; Dana Osman; Tarek Osman
Journal:  Int Urol Nephrol       Date:  2021-05-01       Impact factor: 2.370

2.  Water vapor therapy (Rezūm) for lower urinary tract symptoms related to benign prostatic hyperplasia: early results from the first Italian multicentric study.

Authors:  Giampaolo Siena; L Cindolo; G Ferrari; D Maruzzi; G Fasolis; S V Condorelli; F Varvello; F Visalli; S Rabito; S Toso; S Caroassai; A Mari; L Viola; B K Somani; M Carini
Journal:  World J Urol       Date:  2021-03-31       Impact factor: 4.226

Review 3.  Emerging Data on the Safety and Efficacy of Transurethral Water Vapour Therapy for Benign Prostatic Hyperplasia.

Authors:  Patrick Jones; Giampaolo Siena; B M Zeeshan Hameed; Bhaskar K Somani
Journal:  Res Rep Urol       Date:  2021-05-20
  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.